EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer

Hiroaki Nagano iD, Akimasa Ichinoe iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e94 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Hiroaki Nagano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan. nagano.hiroaki@twm…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cytoreduction Surgical Procedures, Peritoneal Lavage, Peritoneal Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to evaluate the significance of peritoneal washing cytology (PWC) as a predictive factor of the long-term benefits of secondary debulking surgery (SDS) for ovarian cancer (OC). METHODS: We retrospectively reviewed the clinical records of patients with OC who underwent SDS for intraperitoneal recurrence (IPR). Various clinical data points were investigated, including the residual tumor size at SDS, PWC results at SDS, progression-free survival (PFS), and overall survival (OS). RESULTS: Between 2007 and 2022, 207 patients with ovarian, fallopian, or peritoneal cancers were treated at our institution. IPR occurred in 49 patients, 20 of whom underwent SDS. This study included 18 patients, excluding 2 patients with squamous cell carcinoma. Complete resection of the SDS was achieved in 15 patients. PWC was negative in 12 patients but positive in 6; ascites was not observed in any patient. IPR occurred in all PWC-positive patients after SDS, although 3 patients had no residual tumors. In contrast, only 4 of the 12 PWC-negative patients (all without residual tumors) experienced IPR during follow-up (median: 78 months), 2 of whom had secondary IPR at SDS. The association between PWC and IPR after SDS was significant (p=0.009, Fisher's exact test). The PFS and OS after SDS were significantly higher in the PWC-negative group than in the PWC-positive group. CONCLUSION: PWC is a significant predictor of the long-term benefit of SDS in patients with OC and IPR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCytoreduction Surgical ProceduresPeritoneal LavagePeritoneal NeoplasmsHumansFemaleRetrospective StudiesMiddle AgedAgedAdultNeoplasm Recurrence, LocalNeoplasm, ResidualProgression-Free SurvivalAged, 80 and over

Stichwörter der Autor:innen

Cytological TechniquesCytoreductive SurgeryOvarian Neoplasms

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan. nagano.hiroaki@twmu.ac.jp.
  • Department of Obstetrics and Gynecology, Tokyo Women's Medical University School of Medicine, Adachi Medical Center, Tokyo, Japan.

ORCID-Profile: Hiroaki Nagano, Akimasa Ichinoe

Zitieren

APA

Nagano, H., & Ichinoe, A. (2026). Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e94

Vancouver

Nagano H, Ichinoe A. Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e94

BibTeX
@article{Nagano2026,
  author = {Nagano, Hiroaki and Ichinoe, Akimasa},
  title = {Significance of peritoneal washing cytology as a predictive factor for the long-term benefit of secondary debulking surgery in ovarian cancer},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e94}
}
Kostenlos starten →